1061 — Essex Bio-Technology Income Statement
0.000.00%
Last trade - 00:00- HK$1.25bn
- HK$1.03bn
- HK$1.71bn
- 94
- 94
- 27
- 88
Annual income statement for Essex Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,279 | 978 | 1,638 | 1,318 | 1,707 |
| Cost of Revenue | |||||
| Gross Profit | 1,033 | 794 | 1,396 | 1,189 | 1,539 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 921 | 726 | 1,234 | 1,046 | 1,348 |
| Operating Profit | 359 | 252 | 404 | 272 | 359 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 352 | 251 | 394 | 260 | 346 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 303 | 219 | 346 | 225 | 275 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 303 | 219 | 346 | 225 | 275 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 309 | 225 | 350 | 229 | 279 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.512 | 0.383 | 0.582 | 0.439 | 0.479 |
| Dividends per Share |